Psychedelic Compounds-Based Stocks Index Imploding
May 14, 2022 at 09:00 AM EDT
Our index of Psychedelic Compounds-Based Drug Stocks tracking clinical-stage startups still in R&D is down 60% YTD; it's -78% from its 2021 high.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.